Skip to main content

Table 2 Utilization of Diabetes Medication for Type 2 diabetes, Saskatchewan 2001

From: Utilization of diabetes medication and cost of testing supplies in Saskatchewan, 2001

Therapy Number of Patients with Type 2 Diabetes % of Total Patients with Type 2 Diabetes (n = 37625) % of Type 2 Diabetes Patients Receiving Antidiabetic Therapy (n = 23,468)
Monotherapy 12814 34.1 54.6
   SU 4803 12.8 20.5
   Met 5767 15.3 24.6
   TZD 32 0.1 0.1
   Insulin 2212 5.9 9.4
Oral Combination Therapy 7493 19.9 31.9
   SFU+Met 6764 18.0 28.8
   SFU+TZD 59 0.2 0.3
   Met+TZD 137 0.4 0.6
   SFU+Met+TZD 533 1.4 2.3
Oral + Insulin Combination 2151 5.7 9.2
   SFU+Ins 142 0.4 0.6
   Met+Ins 1202 3.2 5.1
   TZD+Ins 53 0.1 0.2
   SFU+Met+Ins 554 1.5 2.4
   SFU+TZD+Ins 15 0.0 0.1
   Met+TZD+Ins 88 0.2 0.4
   SFU+Met+TZD+Ins 97 0.3 0.4
Other Antidiabetic Drugs 1010 2.7 4.3
No diabetes drugs 14157 37.6 -
Total 37625 100 100